Beyond 5-year survival. A report from the Cooperative Osteosarcoma Study Group (COSS).

This benchmark analysis clearly defined risk factors for the further course of 5-year survivors from osteosarcoma. It argues for large disease-oriented databases as well as for very long follow-up periods. Novel findings will most likely require innovative statistical models to analyze such cohorts.